| |
|
| |
 |
| |
| Executive Management |
| |
| |
|
|
 |
 |
 |
| |
|
|
D A Prasanna
Chairman and Managing Director
| Close |
|
|
D A Prasanna
Chairman and Managing Director
As a founder, he has mapped the vision and strategy for the organization. He has experience in leveraging Asian competitiveness building successful global business in medical technology for GE and software for Wipro. As Exec Chairman of the Manipal Group, his focus was on developing a research thrust for the Group. Considered a thought leader in Health care and Life Sciences, he has worked in global leadership positions in GE and was Vice Chairman of Wipro. He serves on the board of various Pharma companies and Research institutes.
Prasanna is acknowledged in the healthcare sector as the pioneer in creating a market for high tech. medical equipment and delivering clinical excellence at low patient fees in Asian Hospitals, through innovative strategies. As the startup CEO of GE Medical in India, he also developed a $330 m Global Business in healthcare for GE Medical Systems (GEMS) by leveraging India's competitiveness taking the company from no 5 to No 1. He has also been a founding member of Wipro's team that initiated the company's entry into IT and was Vice Chairman of Wipro Ltd.
He is an independent Director of Take Solutions Ltd. He serves on the Governing Council of Center for Policy Research, India's leading Think Tank and of T A Pai Management Institute, a reputed Business School. He is a Trustee on Shriram Ownership Trust, which shapes the strategy of Shriram group of companies. He has served as Chairman of GEBEL, GEMS IT Ltd and GE X-Ray(South Asia) and Director of GE Yokogawa Medical Systems Ltd, Japan and GE Samsung Ltd, Korea, Wipro GE Medical Systems Ltd, India and Shasun Chemical & Drugs Ltd India. He brings rich experience in pharma and healthcare.
Mr. Prasanna is an alumnus of IIM Ahmedabad & GE Global Business Leadership Program at Crotonville. |
|
|
Klaus D. Wiedey, MD
Managing Director and CEO
Ecron Acunova Europe
| Close |
|
|
Klaus D. Wiedey, MD
Managing Director and CEO Ecron Acunova Europe
As founder and CEO of Ecron in Europe, Dr Wiedey successfully led the company for more than 2 decades. He focuses on leveraging the company’s growth, its potential and globalization, while cultivating its quality, values and reputation.
Dr Wiedey has 35 years experience in the pharmaceutical and CRO industry. Prior to founding Ecron in 1986, Dr Wiedey was Head of International Clinical Research of the Section Overseas at Boehringer Mannheim, Medical Director and Vice President at Basotherm, and Executive Medical Director for the German Operative Unit of Byk-Gulden (later Altana/Nycomed).
Dr Wiedey is member of the International Society for Clinical Biostatistics, the European Forum for GCP and the International Society for the Economic Evaluation of Medicines. Dr Wiedey is a speaker at various international forums on clinical research.
Dr Wiedey is alumnus of Albert Ludwig University, Freiburg from where he graduated as MD. His specializations include clinical pharmacology and medical informatics and he holds a GDPharMed Diploma in Pharmaceutical Medicine. |
|
|
|
Klemens Schuette
Managing Director
Ecron Acunova GmbH
| Close |
|
|
Klemens Schuette
Managing Director Ecron Acunova GmbH
Mr Schuette brings a vast experience of over 20 years in the pharmaceutical and CRO industry. Before joining EA, Mr Schuette was the Chief Operating and Chief Business Officer of the Ergomed Group as well as their Managing Director in Germany & UK.
Prior to that he was a Board Member and Managing Director Germany of the British site management organisation Intercern. For a decade, he served as Director of Clinical Operations and other positions at ASTA Medica AG in Frankfurt, Germany.
Mr Schuette is a member of several medical and scientific societies, studied Biology/Biochemistry in Constance (Germany) and Gainesville (Florida, US) and received a Master in Science in 1988 by the Faculty of Biology of the University of Constance (Germany). |
|
|
|
| |
|
|
|
 |
 |
| |
|
Surinder Kher, BSc., MBBS
Chief Executive Officer - Asia
| Close |
|
|
Surinder Kher, BSc., MBBS
Chief Executive Officer - Asia
Dr. Kher as Chief Executive Officer is accountable for managing and accelerating the growth of Asia business.
Surinder Kher is a Physician by training and practiced medicine for six years before joining Pharma. He graduated from Medical College, Srinagar, India. Prior to joining us, Surinder was Senior Vice President – Clinical & Regulatory Development in Vanthys, a Jubilant – Eli Lilly joint venture. Surinder spent his initial eight years at Eli Lilly, where he was part of clinical research team that initiated GCP studies in India. His experience in clinical research extends from clinical study management, pharmaco-vigilance, quality-assurance, regulatory affairs to overall strategic business planning covering various therapeutic areas including diabetes, oncology, neuro-sciences and infectious diseases.
Later, Surinder served as COO at Diagno Search Life Sciences (iGATE) for two years where besides responsible for business operations he raised growth funds that lead to acquisition of Diagno Search by iGATE. As CEO Clinsys Clinical Research (A Jubilant CRO), Surinder established the business including a 68 bed phase-I facility and achieved organic annual growth of more than 100% for three years. He was responsible for the acquisition of a CRO which became Clinsys US. He served on Clinsys Board of Directors as an Executive Director.
Professionally Surinder is associated with various clinical research bodies as Advisor and invited speaker at key international meetings. He chairs National Clinical Trials Taskforce of Federation of Indian Chamber of Commerce and Industries (FICCI) and on committees constituted by the Ministry of Health on regulatory reforms initiatives in India.
|
|
|
|
Kohkan Shamsi, MD PhD
CEO Ecron Acunova US
| Close |
|
|
Kohkan Shamsi, MD PhD
CEO Ecron Acunova US
Kohkan Shamsi MD, PhD is a radiologist and has more than 20 years of pharmaceutical, regulatory, clinical and academic experience.
Dr. Shamsi started his career as a Radiologist with Ministry of Health, Saudi Arabia. Then he joined the department of radiology in Antwerp University Hospital, Belgium where he completed his PhD. He moved to Berlin and worked as Research Physician in Diagnostic Imaging at Schering AG, Berlin, Germany. After working for about 5 years in Germany he was transferred to Berlex Inc. New Jersey, USA (a subsidiary of Schering AG) where he has worked for about 8 years as Senior Associate Director, Clinical Development and rose to the position of Head, Medical Development of Diagnostic Imaging & Radio pharmaceuticals & Head of Global Medical Imaging.
Dr. Shamsi has conceptualized, coordinated, and executed over 25 multi-center, international clinical trials (phase I - phase III) to develop new MRI contrast agents for oncology imaging, CNS, Magnetic Resonance Angiography and cardiac imaging. These trials were performed in Europe, the USA, South America and Australia and India. He was one of the first at Schering AG to leverage emerging markets like Latin America and India in clinical trials.
Dr. Shamsi has submitted many NDAs in Europe, USA and Japan with successful outcomes and interacts with regulatory agencies for IND, PMA, pre NDA and other regulatory meetings.
Dr Shamsi has published extensively including book, book chapter and more than 90 papers and abstracts in indexed journals. He regularly participate in various scientific forums, meetings, initiatives for image standardization, image evaluations, and image management for drug development and lectures in global meetings and conferences.
Since 2006, he has been with Ecron Acunova in leadership positions and continues to contribute to its phenomenal growth. |
|
|
| |
|
|
|
|
